Physician profile
Akram Kholoki
NPI 1164598504
$11,262.01
in general payments reported to CMS, 2019-2025
48 companies · $1,659 in 2025
The $1,659 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,963 · 2020: $1,086 · 2021: $1,826 · 2022: $2,043 · 2023: $976 · 2024: $1,709 · 2025: $1,659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,344.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,291.43 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $984.73 | 2019-2024 | Farxiga, Brilinta |
| Merck Sharp & Dohme LLC | $749.29 | 2021-2025 | Verquvo |
| Medtronic, INC. | $711.73 | 2021-2025 | Symplicity G3, Heli-Fx Endoanchor System, Abre |
| Esperion Therapeutics, INC. | $664.05 | 2020-2025 | Nexletol |
| Boston Scientific Corporation | $631.20 | 2019-2025 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $583.27 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $513.53 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $503.62 | 2019-2025 | Jardiance |
| Pfizer INC. | $373.26 | 2019-2025 | |
| Cardiovascular Systems INC. | $348.82 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $335.65 | 2019-2023 | |
| Abiomed | $322.78 | 2022-2025 | Impella |
| Chiesi USA, INC. | $309.17 | 2020-2021 | |
| Aop Health US, LLC | $286.97 | 2025 | Rapiblyk |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akram Kholoki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.